Related Experiment Video
Updated: Aug 17, 2026

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
Published on: October 18, 2022
Abstract:
Ideal gene therapy implies correction of a genetic mutation at the site of its localization on the chromosome. This can be done only with homologous recombination. In prokaryotes, two mechanisms of homologous recombination are provided by two types of recombinases, an ATP-dependent RecA protein and an ATP-independent renaturase. In eukaryotes both the ATP-dependent and ATP-independent DNA transferases have been revealed, among which functionally RecA-like enzymes were also found. The unique properties of RecA-like proteins suggest that these enzymes promote recombination both in pro- and eukaryotes. According to recent observations, the mitotic eukaryotic cells do possess a potential for homologous recombination. However to realize it the donor DNA should be reasonably long and be maximally homologous to the recipient DNA. Other possibilities of optimizing the gene therapy process are discussed.
More Related Videos
03:52Suspension Culture Production and Purification of Adeno-Associated Virus by Iodixanol Density Gradient Centrifugation for In Vivo Applications
Published on: February 9, 2024
10:00Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery
Published on: February 17, 2026
Related Concept Videos
What is Genetic Engineering?
Gene Therapy
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets
Microorganisms in Medicine and Therapeutics